Article Information
History
- September 15, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 15, 2021 - 10:07).
- Version 2 (September 17, 2021 - 00:01).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daniele Focosi1,#,
- Massimo Franchini2,
- Liise-anne Pirofski3,
- Thierry Burnouf4,
- Nigel Paneth5,
- Michael J. Joyner6 and
- Arturo Casadevall7
- 1North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
- 2Division of Transfusion Medicine, Carlo Poma Hospital, 46100 Mantua, Italy; massimo.franchini{at}asst-mantova.it
- 3Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, New York, NY 10467, USA; l.pirofski{at}einsteinmed.org
- 4Graduate Institute of Biomedical Materials and Tissue Engineering & International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taiwan; thburnouf{at}gmail.com
- 5Departments of Epidemiology & Biostatistics and Pediatrics & Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, paneth{at}msu.edu
- 6Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA; joyner.michael{at}mayo.edu
- 7Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, MD, USA; acasade1{at}jhu.edu
- ↵#corresponding author: via Paradisa 2, 56124 Pisa, Italy. E-mail: daniele.focosi{at}gmail.com
Author contributions: D.F. designed the paper, analyzed the data, and wrote the first draft. M.F., M.J.J., T.B., L.P., N.P. and A.C. revised the manuscript. All authors approved the final version.
Posted September 15, 2021.
COVID-19 convalescent plasma and randomized clinical trials: rebuilding confidence by explaining failures and finding signals of efficac
